POM POMDOCTOR Ltd
Fundamentals / CIK 0001877971 / CNYPOMDOCTOR Ltd reported ¥399.9M in revenue and a net loss of ¥212.6M for the fiscal year ended December 31, 2025 (up 16.7% year over year), with a 13.1% gross margin and a -29.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open POM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025¥399.9M +16.7% YoY
-
Operating Income FY 2025-¥118.6M -29.7% margin
-
Net Income FY 2025-¥212.6M -53.2% net margin
-
Diluted EPS FY 2025-¥21.96 Split-adjusted
-
Free Cash Flow FY 2025-¥149.5M -37.4% FCF margin
-
Cash & ST Investments Dec 31, 2025¥9.58M Total debt: ¥55.84M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in CNY.
Financial statements and ratios
Reported in CNY. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in CNY · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | ¥399.9M | ¥342.6M | ¥304.9M |
| Cost of Revenue | ¥347.6M | ¥294.9M | ¥266.1M |
| Gross Profit | ¥52.28M | ¥47.69M | ¥38.72M |
| Research & Development | ¥12.86M | ¥3.00M | ¥3.37M |
| Selling, General & Admin | ¥155.9M | ¥68.24M | ¥55.99M |
| Total Operating Expenses | ¥170.9M | ¥73.49M | ¥60.97M |
| Operating Income | -¥118.6M | -¥25.79M | -¥22.25M |
| EBITDA | -¥118.5M | -¥25.66M | -¥22.14M |
| Interest Expense | ¥3.94M | ¥3.63M | ¥3.00M |
| Income Before Tax | -¥130.9M | -¥37.37M | -¥36.95M |
| Income Tax Expense | ¥375 | -- | -- |
| Net Income | -¥212.6M | -¥143.4M | -¥145.4M |
| Basic EPS | -¥21.96 | -¥22.72 | -¥23.04 |
| Diluted EPS | -¥21.96 | -¥22.72 | -¥23.04 |
| Basic Shares Outstanding | 9.7M | 6.3M | 6.3M |
| Diluted Shares Outstanding | 9.7M | 6.3M | 6.3M |
Income Statement (Quarterly) · Reported in CNY · Newest filing period first.
Balance Sheet (Annual) · Reported in CNY · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | ¥9.58M | ¥7.65M |
| Cash & Short-Term Investments | ¥9.58M | ¥7.65M |
| Accounts Receivable, Net | ¥18.44M | ¥8.37M |
| Inventory | ¥8.28M | ¥9.17M |
| Other Current Assets | ¥3.56M | ¥2.68M |
| Total Current Assets | ¥105.0M | ¥37.50M |
| Property, Plant & Equipment, Net | ¥1.25M | ¥461K |
| Other Non-Current Assets | ¥1.34M | ¥831K |
| Total Non-Current Assets | ¥2.59M | ¥8.73M |
| Total Assets | ¥107.6M | ¥46.23M |
| Accounts Payable | ¥44.81M | ¥25.32M |
| Short-Term Debt | ¥53.00M | ¥34.96M |
| Other Current Liabilities | -- | ¥2.08M |
| Total Current Liabilities | ¥218.2M | ¥179.1M |
| Total Non-Current Liabilities | ¥370.7M | ¥366.8M |
| Total Liabilities | ¥588.9M | ¥545.9M |
| Total Debt (incl. Leases) | ¥55.84M | ¥38.02M |
| Retained Earnings | -¥2.48B | -¥2.26B |
| Accumulated Other Comp. Income | -¥1.75M | -¥5.2K |
| Total Stockholders' Equity | -¥454.0M | -¥2.26B |
| Total Equity | -¥481.3M | -¥2.26B |
Balance Sheet (Quarterly) · Reported in CNY · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash & Cash Equivalents | ¥9.58M | ¥7.65M |
| Cash & Short-Term Investments | ¥9.58M | ¥7.65M |
| Accounts Receivable, Net | ¥18.44M | ¥8.37M |
| Inventory | ¥8.28M | ¥9.17M |
| Other Current Assets | ¥3.56M | ¥2.68M |
| Total Current Assets | ¥105.0M | ¥37.50M |
| Property, Plant & Equipment, Net | ¥1.25M | ¥461K |
| Other Non-Current Assets | ¥1.34M | ¥831K |
| Total Non-Current Assets | ¥2.59M | ¥8.73M |
| Total Assets | ¥107.6M | ¥46.23M |
| Accounts Payable | ¥44.81M | ¥25.32M |
| Short-Term Debt | ¥53.00M | ¥34.96M |
| Other Current Liabilities | -- | ¥2.08M |
| Total Current Liabilities | ¥218.2M | ¥179.1M |
| Total Non-Current Liabilities | ¥370.7M | ¥366.8M |
| Total Liabilities | ¥588.9M | ¥545.9M |
| Total Debt (incl. Leases) | ¥55.84M | ¥38.02M |
| Retained Earnings | -¥2.48B | -¥2.26B |
| Accumulated Other Comp. Income | -¥1.75M | -¥5.2K |
| Total Stockholders' Equity | -¥454.0M | -¥2.26B |
| Total Equity | -¥481.3M | -¥2.26B |
Cash Flow Statement (Annual) · Reported in CNY · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -¥130.9M | -¥37.37M | -¥36.95M |
| Depreciation & Amortization | ¥149K | ¥135K | ¥112K |
| Stock-Based Compensation | ¥16.42M | -- | -- |
| Change in Receivables | -¥10.10M | ¥20.31M | -¥1.27M |
| Change in Inventory | -¥998K | ¥3.03M | -¥5.00M |
| Change in Payables | ¥19.49M | -¥16.25M | -¥1.63M |
| Operating Cash Flow | -¥148.5M | -¥16.13M | -¥45.80M |
| Capital Expenditure | -¥1.01M | -¥38K | -¥112K |
| Free Cash Flow | -¥149.5M | -¥16.17M | -¥45.91M |
| Investing Cash Flow | -¥1.61M | -¥33K | -¥112K |
| Financing Cash Flow | ¥153.9M | ¥17.02M | ¥50.07M |
| Net Change in Cash | ¥1.93M | ¥847K | ¥4.16M |
Cash Flow Statement (Quarterly) · Reported in CNY · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Gross Margin | 13.1% | 13.9% | 12.7% |
| Operating Margin | -29.7% | -7.5% | -7.3% |
| Net Profit Margin | -53.2% | -41.9% | -47.7% |
| Return on Assets (ROA) | -197.6% | -310.1% | -- |
| Current Ratio | 0.48x | 0.21x | -- |
| Quick Ratio | 0.44x | 0.16x | -- |
| Revenue Growth (YoY) | +16.7% | +12.4% | -- |
| Gross Profit Growth (YoY) | +9.6% | +23.2% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.